New hope for pancreatic cancer? early trial combines novel drug with chemo
NCT ID NCT06059001
First seen Jan 16, 2026 · Last updated May 20, 2026 · Updated 17 times
Summary
This early-stage trial tests a new drug called OMO-103, given together with standard chemotherapy, in 26 people with advanced pancreatic cancer that has spread. The main goals are to check the safety of the combination and see if it helps shrink tumors. Participants must not have had prior treatment for their advanced disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Hospital Gregorio Marañon
Madrid, Madrid, 28007, Spain
-
Hospital Miguel Servet
Zaragoza, Zaragoza, 5009, Spain
-
Hospital Regional Universitario de Málaga
Málaga, Spain, 29010, Spain
-
Hospital Universitario Marqués de Valdecilla
Santander, Cantabria, 39008, Spain
-
Hospital Vall d´Hebrón
Barcelona, Barcelona, 08035, Spain
-
ICO Hopsitalet
L'Hospitalet de Llobregat, Barcelona, 08908, Spain
Conditions
Explore the condition pages connected to this study.